FDA approves antibiotic for treatment of urinary infections
The Food and Drug Administration on Wednesday approved the sale of an antibiotic to treat urinary tract infections in women, giving U.S. health care providers a powerful new tool to fight a common infection that is increasingly resistant to the existing suite of antimicrobial drugs .The drug, pivmecillinam, has been used in Europe for more than 40 years, where it is often first-line therapy for women with uncomplicated urinary tract infections, meaning the infection is confined to the bladder and has not reached the kidneys. The drug will be marketed in the United States as Pivya and will be made available by prescription to women aged 18 and older.It's the first time in two decades that the FDA has approved a new antibiotic for urinary tract infections, which affect 30 million Americ...